At the time of writing, Ocular Therapeutix Inc [OCUL] stock is trading at $11.33, up 2.16%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The OCUL shares have gain 15.85% over the last week, with a monthly amount glided 25.33%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, TD Cowen upgraded its rating to Buy on June 20, 2024, and elevated its price target to $11. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $15 on February 09, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $18 as its price target on April 21, 2023. In a note dated August 10, 2021, H.C. Wainwright upgraded an Buy rating on this stock but restated the target price of $17.
For the past year, the stock price of Ocular Therapeutix Inc fluctuated between $2.00 and $11.58. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. Ocular Therapeutix Inc [NASDAQ: OCUL] shares were valued at $11.33 at the most recent close of the market. An investor can expect a potential return of 54.46% based on the average OCUL price forecast.
Analyzing the OCUL fundamentals
According to Ocular Therapeutix Inc [NASDAQ:OCUL], the company’s sales were 61.10M for trailing twelve months, which represents an 8.26% jump. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -1.88%, Pretax Profit Margin comes in at -2.27%, and Net Profit Margin reading is -2.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.63 and Total Capital is -0.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.15 points at the first support level, and at 10.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.51, and for the 2nd resistance point, it is at 11.68.
Ratios To Look Out For
It is important to note that Ocular Therapeutix Inc [NASDAQ:OCUL] has a current ratio of 16.64. In addition, the Quick Ratio stands at 16.55 and the Cash Ratio stands at 15.34. Considering the valuation of this stock, the price to sales ratio is 28.91, the price to book ratio is 4.67.
Transactions by insiders
Recent insider trading involved PHILIP C. STRASSBURGER, Officer, that happened on Oct 16 ’24 when 13125.0 shares were purchased. Chief Strategy Officer, Nayak Sanjay completed a deal on Aug 23 ’24 to sell 1832.0 shares. Meanwhile, Dugel Pravin sold 20880.0 shares on Aug 23 ’24.
